Document Classification

Section Type: RESULTS

Text: Compared with baseline, the levels of glycosylated hemoglobin A1c (HbA1c) at the end of 12 weeks treatment decreased from 10. 77 % to 7. 72 % (P < 0. 05) in Yousilin R group and from 10. 33 % to 7. 62 % (P < 0. 05) in Novolin R group, 2-hour postprandial plasma glucose (2hPG) decreased from 15. 49 mmol/L to 9. 72 mmol/L (P < 0. 05) in Yousilin R group and from 15. 33 mmol/L to 10. 07 mmol/L (P < 0. 05) in Novolin R group, and fasting plasma glucose (FPG) decreased from 10. 90 mmol/L to 7. 31 mmol/L (P < 0. 05) in Yousilin R group and from 10. 22 mmol/L to 7. 21 mmol/L (P < 0. 05) in Novolin R group.